Firsthand Technology Value Fund Inc Stock Price, News & Analysis

Firsthand Technology Value Fund (NASDAQ: SVVC) reported its financial results for the fiscal year ended December 31, 2021. The Fund's net assets decreased to approximately $94.8 million or $13.75 per share, down from $102.1 million or $14.82 per share in 2020. The portfolio includes $91.1 million in public and private securities, with $0.09 per share in cash equivalents. Investment income was about $6.3 million, but net realized and unrealized losses reached $10.45 million for the year. The Fund's strategy focuses on enhancing portfolio performance and exit opportunities.

Firsthand Technology Value Fund (NASDAQ: SVVC) announced its top five holdings as of January 31, 2022. These include Revasum (32.8%), IntraOp Medical (27.1%), Wrightspeed (23.2%), Pivotal Systems (6.8%), and Hera Systems (5.5%), collectively accounting for 95.3% of the Fund's estimated total investments of approximately $99.9 million or $14.50 per share. The Fund primarily focuses on technology and cleantech investments and plans to release full financial statements in May 2022, detailing its performance and investment strategies.

Firsthand Technology Value Fund (NASDAQ: SVVC) announced its preliminary net asset value (NAV) of $13.75 as of December 31, 2021. The Fund's top five holdings are IntraOp Medical, Wrightspeed, Revasum, Pivotal Systems, and Hera Systems, representing a combined 91.3% of its net assets. Total investments reached $91.1 million, with a per-share valuation of $13.22. The annual report, including detailed financial statements and investment schedules, will be available with the Form 10-K filing in March 2022.

As of November 30, 2021, Firsthand Technology Value Fund (NASDAQ: SVVC) reported estimated total investments of approximately $97.1 million, equating to $14.09 per share. The top five holdings comprise 93.4% of these investments. The leading position is IntraOp Medical Corp., representing about 33.0% of the Fund's investments, followed by Wrightspeed, Revasum, Pivotal Systems, and Hera Systems. Cash and equivalents accounted for $0.28 per share. Comprehensive financial details will be available in the upcoming Form 10-K annual report.

The Firsthand Technology Value Fund (NASDAQ: SVVC) reported its top five holdings as of October 31, 2021, with a total investment value of approximately $105.1 million, or $15.25 per share. Major investments include IntraOp Medical (29.6%), Wrightspeed (23.6%), Revasum (22.8%), Pivotal Systems (10.4%), and Hera Systems (5.6%). These top holdings represent 91.9% of the Fund's total investments. A complete financial report will be available in the Fund’s annual report on Form 10-K by March 2022.

Firsthand Technology Value Fund (NASDAQ: SVVC) reported third-quarter financial results for the period ending September 30, 2021. The Fund's net assets decreased to approximately $98.8 million, or $14.33 per share, down from $107.3 million or $15.57 per share at the end of Q2 2021. The Fund's portfolio, comprised of public and private securities, is valued at $96.5 million. Investment income for the quarter was around $1.5 million, with net realized and unrealized losses of approximately $9.29 million.

Firsthand Technology Value Fund (NASDAQ: SVVC) announced its preliminary net asset value (NAV) of $14.33 as of September 30, 2021. The Fund's top holdings include IntraOp Medical, Wrightspeed, Pivotal Systems, Revasum, and Hera Systems, which together represent 93.0% of its preliminary net assets. The total investments amount to $96.5 million, approximately $14.00 per share. The quarterly report, providing complete financial statements, will be available in November 2021, offering further insights into the Fund's performance and strategies.

Firsthand Technology Value Fund (NASDAQ: SVVC) revealed its top five holdings as of August 31, 2021. The top investments include IntraOp Medical (28.2%), Wrightspeed (25.2%), Pivotal Systems (21.9%), Revasum (14.2%), and Hera Systems (5.2%), together constituting 94.6% of the Fund’s estimated total investments of approximately $107.7 million, or $15.63 per share. The complete financial details will be available in the upcoming quarterly report in November 2021. The Fund focuses on long-term growth through investments in technology and cleantech companies.

Firsthand Technology Value Fund (NASDAQ: SVVC) has disclosed its top five holdings as of July 31, 2021, which represent 93.3% of its estimated total investments of approximately $107.1 million, or $15.54 per share. The holdings include:

• IntraOp Medical - 28.3% of total investments.
• Wrightspeed - 24.4% of total investments.
• Pivotal Systems - 22.6% of total investments.
• Revasum - 12.8% of total investments.
• Hera Systems - 5.1% of total investments.

More detailed financial statements will be available in the quarterly report in November 2021.